2011
DOI: 10.1016/j.gene.2011.07.018
|View full text |Cite
|
Sign up to set email alerts
|

RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 36 publications
1
9
0
2
Order By: Relevance
“…Finally, Lats2 is a negative regulator of cell growth and a tissue-specific inhibitor of cell size (2830). Similar to Foxm1 , p53 remained bound to a Lats2 p53RE at 24h post-PH (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Finally, Lats2 is a negative regulator of cell growth and a tissue-specific inhibitor of cell size (2830). Similar to Foxm1 , p53 remained bound to a Lats2 p53RE at 24h post-PH (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Downregulation of RhoBTB2 was further observed in lung, bladder, bone and gastric cancer (Cho et al 2009;Shi et al 2008;Dong et al 2012;Jin et al 2013). Obtained in breast cancer cells, evidence suggests that RhoBTB2 exerts a tumor-suppressive function by inhibiting cancer cell proliferation, migration and invasiveness (Ling et al 2014;Mao et al 2011). Similar anti-tumorigenic properties were also found for the other RhoBTB isoforms.…”
Section: Rhobtb Lkb1 (Stk11) Hippo Pathway Ubiquitinationmentioning
confidence: 63%
“…Recent researches indicate that DBC2 participates in diverse cellular activities, significantly influences cellcycle, apoptosis, cytoskeleton and membrane-trafficking pathways (Siripurapu et al, 2005;Chang et al, 2006). DBC2 really plays as an important tumor suppressor gene by inhibiting proliferation, preventing colony formation and promoting the apoptosis of tumor cells (Mao et al, 2011). Successive studies showed that the downregulation of DBC2 was found in 58% (11/19) of breast, 50% (7/14) of lung, and 75% (9/12) of bladder tumor cell lines (Knowles et al, 2005).…”
Section: Discussionmentioning
confidence: 99%